Acusphere executive resigns

Ultrasound contrast developer Acusphere said that senior vice president of clinical research Dr. Richard Walovitch has resigned to pursue another opportunity.

Walovitch's 11-year tenure at Acusphere will come to an end January 9, according to the Watertown, MA-based vendor.

Related Reading

FDA panel rejects Acusphere contrast agent, December 11, 2008

FDA 'concerned' over Acusphere agent, December 9, 2008

Bernstein leaves Acusphere, November 18, 2008

Acusphere's Imagify to get FDA review, October 13, 2008

Acusphere taps new VP, September 25, 2008

Copyright © 2009 AuntMinnie.com

Page 1 of 509
Next Page